JCR Pharmaceuticals Co., Ltd.
Symbol: JCRRF
PNK
6.2
USDTržní cena dnes
18.8882
Poměr P/E
-0.0016
Poměr PEG
773.77M
MRK Cap
- 0.00%
Výnos DIV
JCR Pharmaceuticals Co., Ltd. (JCRRF) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 13278 | 30977 | 26260 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -214 | 244 | -225 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 11137 | 15585 | 8183 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 18514 | 14636 | 13554 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 4873 | 990 | 548 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 47802 | 62188 | 48545 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 32681 | 26782 | 17172 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 3652 | 2960 | 3232 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3652 | 2960 | 3232 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 9081 | 1986 | 2797 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 1357 | 2433 | 1739 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 362 | 783 | 296 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 47133 | 34944 | 25236 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 2 | 2 | 3 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 94937 | 97134 | 73784 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 1563 | 1324 | 2932 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 17300 | 15150 | 12850 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 33 | 5915 | 2646 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5500 | 2950 | 5250 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | -428 | -343 | -378 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 12975 | 13472 | 9687 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6763 | 3994 | 6203 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 73 | 44 | 42 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 42525 | 46048 | 35231 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 9061 | 9061 | 9061 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 34273 | 33241 | 20904 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1421 | 1184 | 1159 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 7406 | 7395 | 7255 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 52161 | 50881 | 38379 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 94937 | 97134 | 73784 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 251 | 205 | 174 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 52412 | 51086 | 38553 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 8867 | 2230 | 2572 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 22800 | 18100 | 18100 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 9522 | -12633 | -8160 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 5412 | 19404 | 8653 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1997 | 1945 | 1892 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -9221 | -3074 | -983 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 173 | 177 | 149 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2956 | -9030 | 323 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | 3269 | -7501 | -204 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -3877 | -1082 | -4699 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 238 | -1608 | 2253 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2586 | 1161 | 2973 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -905 | -133 | 307 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -8560 | -11333 | -7527 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -6717 | 8167 | -2747 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -906 | -300 | -391 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 259 | 300 | 584 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 922 | -84 | 6791 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -15002 | -3250 | -3290 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -3050 | -750 | -650 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 10 | 10 | 13 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -10 | -10 | -13 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2739 | -2169 | -1083 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 7737 | 740 | 10037 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 1948 | -2179 | 8304 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1099 | 612 | -22 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -17455 | 4473 | 15332 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 13278 | 30733 | 26260 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 30733 | 26260 | 10928 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -5500 | 9289 | 10341 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -8560 | -11333 | -7527 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -14060 | -2044 | 2814 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 34343 | 51082 | 30085 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 8886 | 10461 | 7812 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 25457 | 40621 | 22273 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 58 | 38 | 61 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 20480 | 20686 | 14003 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 29366 | 31147 | 21815 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 33 | 7 | 7 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 44 | 45 | 42 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 437 | -529 | 384 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 58 | 38 | 61 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 437 | -529 | 384 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 44 | 45 | 42 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1997 | 1945 | 1892 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | 4975 | 19933 | 8269 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 5412 | 19404 | 8653 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1625 | 4886 | 1764 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | 3772 | 14507 | 6892 |
Často kladené otázky
Co je JCR Pharmaceuticals Co., Ltd. (JCRRF) celková aktiva?
JCR Pharmaceuticals Co., Ltd. (JCRRF) celková aktiva jsou 94937000000.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.748.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je 45.128.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.130.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.189.
Co je JCR Pharmaceuticals Co., Ltd. (JCRRF) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je 3772000000.000.
Jaký je celkový dluh podniku?
Celkový dluh je 22800000000.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 20480000000.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.